paclitaxel has been researched along with Cancer of Oropharnyx in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (52.94) | 29.6817 |
| 2010's | 15 (44.12) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, N; Blair, E; Cipriani, N; Edelstein, DL; Fredebohm, J; Ginat, D; Gooi, Z; Haraf, D; Holtrup, F; Izumchenko, E; Jones, FS; Juloori, A; Karrison, T; Keyser, K; Lingen, M; Pearson, A; Rosenberg, AJ; Sloane, H; Vokes, EE | 1 |
| Belille, E; Brenner, JC; Carey, TE; Goudsmit, CM; Marchiano, E; McHugh, JB; Shuman, AG; Spector, ME; VanKoevering, KK; Walline, HM | 1 |
| Dunn, LA; Fury, MG; Haque, SS; Ho, AA; Katabi, N; Pfister, DG; Sherman, EJ | 1 |
| Agrawal, N; Blair, EA; Brisson, RJ; Dekker, A; Foster, CC; Ginat, DT; Gooi, Z; Haraf, DJ; Karrison, TG; Kochanny, S; Lingen, MW; Melotek, JM; Portugal, L; Seiwert, TY; Villaflor, VM; Vokes, EE | 1 |
| Bellile, E; Bradford, CR; Byrd, S; Carey, TE; Chepeha, DB; Cordell, KG; Dobrosotskaya, IY; Eisbruch, A; Feng, F; Kumar, B; Maxwell, JH; McHugh, JB; Moyer, JS; Prince, ME; Spector, ME; Teknos, T; Urba, S; Walline, HM; Ward, PD; Wolf, GT; Worden, FP | 1 |
| Antonuk, AE; Balter, JM; Cornwall, C; Eisbruch, A; Feng, M; Fernandes, LL; Hunter, KU; McShan, D; Schipper, MJ; Vineberg, KA | 1 |
| Bayley, A; Chan, K; Chen, EX; Chin, S; Diaz-Padilla, I; Hope, A; Hossain, M; Kim, J; Loong, HH; Palma, D; Razak, AR; Read, N; Siu, LL; Waldron, J; Wang, L; Winquist, E | 1 |
| Bellile, E; Bradford, CR; Carey, T; Chanowski, EJ; Chepeha, DB; Chinn, SB; Eisbruch, A; Gallagher, KK; Ibrahim, M; McHugh, JB; Moyer, JS; Prince, ME; Spector, ME; Vainshtein, J; Walline, HM; Wolf, GT; Worden, FP | 1 |
| Arnold, SM; Brill, Y; Dressler, EV; Gleason, JF; Kudrimoti, M; Silver, NL; Valentino, J | 1 |
| Borel, C; Ciftci, S; Debry, C; Dupret-Bories, A; Schmaltz, H; Schultz, P; Takeda-Raguin, C | 1 |
| Hier, M; Kay-Rivest, E; Mascarella, MA; Mlynarek, A; Roskies, M; Sultanem, K | 1 |
| Browne, JD; D'Agostino, RB; Greven, KM; McGuirt, WF; White, DR; Williams, DW | 1 |
| Holzgraefe, M; Schneider, I; Schröder, M | 1 |
| Chen, A; Davis, LW; Edelman, S; Gaultney, J; Grist, W; Khuri, FR; Saba, NF; Shin, DM; Tighiouart, M | 1 |
| Cullen, KJ; Goloubeva, O; Kwok, Y; Ord, R; Parekh, A; Strome, S; Suntharalingam, M; Taylor, R; Wolf, J; Zimrin, A | 1 |
| Guntinas-Lichius, O; Klubmann, JP; Müller, RP; Preuss, SF; Semrau, R; Temming, S | 1 |
| Knecht, R; Laban, S; Münscher, A; Schafhausen, P; Tribius, S; Wang, CJ | 1 |
| Eisbruch, A; Feng, F; Pak, D; Ten Haken, RK; Vineberg, K | 1 |
| Annino, DJ; Balboni, TA; Goguen, LA; Haddad, RI; Lorch, J; Norris, CM; Posner, MR; Sher, DJ; Thotakura, V; Tishler, RB | 1 |
| Aviles, VM; Chalian, AA; Greenberg, MJ; Hershock, D; Jones, H; Machtay, M; Rosenthal, DI; Weber, RS; Weinstein, GS; Williamson, S | 1 |
| Chaudhry, M; Chaudhry, V; Crawford, TO; Griffin, JW; Simmons-O'Brien, E | 1 |
| Becker, A; Bloching, M; Dunst, J; Hänsgen, G; Kuhnt, T; Lotterer, E; Passmann, M; Pelz, T; Pigorsch, S | 1 |
| Egli, F; Jost, L; Moosmann, P; Stahel, RA | 1 |
| Biel, MA; El-Naggar, AK; Machtay, M; Rosenthal, DI; Sinard, RJ; Weber, RS; Yom, SS | 1 |
| Chou, W; Lee, N; Puri, DR | 1 |
| Eckardt, A; Karstens, JH; Wegener, G | 1 |
| Agrawal, A; Grecula, JC; Ozer, E; Rhoades, CA; Schuller, DE; Young, DC | 2 |
| Haraf, DJ; Helenowski, IB; Lazarus, C; Logemann, JA; Maccracken, E; Mittal, BB; Pauloski, BR; Rademaker, AW; Vokes, EE; Vonesh, EF | 1 |
| Cannon, M; Cmelak, AJ; Forastiere, AA; Gillison, M; Goldwasser, MA; Li, S; Murphy, B; Pinto, H; Rosenthal, DI | 1 |
| Bremer, M; Eckardt, A; Hofele, C; Reuter, C; Sinikovic, B | 1 |
| Bradford, CR; Carey, TE; Chepeha, DB; Cordell, KG; D'Silva, NJ; Eisbruch, A; Kumar, B; Kurnit, DM; Lee, JS; Mason, HL; Miller, TH; Prince, ME; Taylor, JM; Teknos, TN; Tsien, CI; Urba, SG; Wallace, NE; Wolf, GT; Worden, FP; Yang, K | 1 |
| Algazy, KM; Aviles, VM; Chalian, AA; Greenberg, MJ; Hershock, D; Machtay, M; Mirza, N; Neubauer, R; Rosenthal, DI; Weber, RS; Weinstein, GS | 1 |
| Kovács, AF; Schiemann, M; Turowski, B | 1 |
1 review(s) available for paclitaxel and Cancer of Oropharnyx
| Article | Year |
|---|---|
Molecular targeting agents in the context of primary chemoradiation strategies.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Disease Progression; ErbB Receptors; Fluorouracil; Head and Neck Neoplasms; Humans; Molecular Targeted Therapy; Oropharyngeal Neoplasms; Paclitaxel; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2013 |
16 trial(s) available for paclitaxel and Cancer of Oropharnyx
| Article | Year |
|---|---|
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cell-Free Nucleic Acids; Chemoradiotherapy; Cisplatin; DNA, Viral; Drug Monitoring; Feasibility Studies; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Prospective Studies; Treatment Outcome; Young Adult | 2022 |
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.
Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Ribavirin | 2018 |
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Survival Rate | 2019 |
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Human papillomavirus 6; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organ Preservation; Oropharyngeal Neoplasms; Paclitaxel; Proportional Hazards Models; Prospective Studies; Pulse Therapy, Drug; Radiotherapy, High-Energy; Risk Assessment; Serologic Tests; Survival Rate; Time Factors; Treatment Outcome | 2014 |
Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Squamous Cell Carcinoma of Head and Neck | 2014 |
Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Drug Administration Schedule; ErbB Receptors; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Prospective Studies; Remission Induction; Squamous Cell Carcinoma of Head and Neck | 2012 |
Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Dose Fractionation, Radiation; Enteral Nutrition; Feasibility Studies; Female; Follow-Up Studies; Germany; Humans; Hypopharyngeal Neoplasms; Leukopenia; Male; Middle Aged; Mucositis; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiation Injuries; Radiotherapy Dosage; Thrombocytopenia | 2011 |
Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neck Dissection; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy Dosage; Treatment Outcome | 2002 |
Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Cohort Studies; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Metastasis; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy Dosage; Stomatitis; Survival Analysis; Time Factors | 2003 |
Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome | 2003 |
Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Otorhinolaryngologic Surgical Procedures; Paclitaxel; Patient Compliance; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome | 2006 |
Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mouth; Oropharyngeal Neoplasms; Paclitaxel; Patient Compliance; Prospective Studies; Survival Rate; Treatment Outcome | 2007 |
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Deglutition Disorders; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Pharyngectomy; Platinum; Radiotherapy, Adjuvant; Recovery of Function; Salvage Therapy; Speech Disorders; Taxoids; Treatment Outcome | 2007 |
Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Preoperative Care; Prognosis; Prospective Studies; Survival Rate | 2007 |
Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Laryngectomy; Neck Dissection; Oropharyngeal Neoplasms; Paclitaxel; Pilot Projects; Prospective Studies; Radiotherapy Dosage; Survival Analysis | 2000 |
Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Docetaxel; Dose Fractionation, Radiation; Drug Tolerance; Feasibility Studies; Female; Humans; Injections, Intra-Arterial; Lymph Node Excision; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Patient Compliance; Pilot Projects; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Survival Analysis; Taxoids | 2002 |
17 other study(ies) available for paclitaxel and Cancer of Oropharnyx
| Article | Year |
|---|---|
An Algorithm to Evaluate Suspected Lung Metastases in Patients with HPV-Associated Oropharyngeal Cancer.
Topics: Algorithms; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Diagnosis, Differential; Female; Human papillomavirus 16; Humans; Immunohistochemistry; In Situ Hybridization; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Paclitaxel; Papillomavirus Infections; Precision Medicine; Prospective Studies | 2018 |
Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cone-Beam Computed Tomography; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organs at Risk; Oropharyngeal Neoplasms; Paclitaxel; Parotid Gland; Prospective Studies; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy Setup Errors; Radiotherapy, Intensity-Modulated; Saliva; Salivation | 2013 |
Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinoma.
Topics: Biomarkers; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Paclitaxel; Predictive Value of Tests; Radiotherapy, Intensity-Modulated; Sensitivity and Specificity | 2016 |
p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer.
Topics: Adult; Antineoplastic Agents; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Gene Expression Profiling; Genes, p16; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomavirus Infections; Remission Induction; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome | 2015 |
Induction chemotherapy before surgery for unresectable head and neck cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Cohort Studies; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Paclitaxel; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome | 2016 |
Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome | 2016 |
Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deglutition Disorders; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Risk Factors | 2008 |
[Carboplatin and paclitaxel induction chemotherapy for patients with oropharynx carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 2008 |
Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.
Topics: Adult; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Analysis; Treatment Outcome | 2009 |
Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation Tolerance; Radiography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Spinal Cord | 2012 |
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.
Topics: Aged; Albumin-Bound Paclitaxel; Albumins; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Panitumumab; Papillomavirus Infections; Proportional Hazards Models; Radiation Tolerance; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids; Treatment Failure | 2012 |
Toxic neuropathy in patients with pre-existing neuropathy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Lupus Erythematosus, Discoid; Lymphoma; Male; Middle Aged; Neural Conduction; Oropharyngeal Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Severity of Illness Index; Thalidomide; Vincristine | 2003 |
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngoscopy; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Palliative Care; Radiation Dosage; Radiation Injuries; Remission Induction; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Osteoradionecrosis; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2005 |
[Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Multicenter Studies as Topic; Neoadjuvant Therapy; Oropharyngeal Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Survival Analysis | 2006 |
Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deglutition; Female; Fluoroscopy; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Paclitaxel; Prospective Studies; Tongue; Video Recording | 2007 |
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Patient Selection; Proportional Hazards Models; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2008 |